Circulating Short-Chain Fatty Acid (SCFA) profiles as a biomarker of gut-brain axis dysfunction: A meta-analysis for the SCFA signature in major depression
Biomedical Journal · 2026-06 · 49 (3) · 100968
DOI: 10.1016/j.bj.2026.100968 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Biomedical Journal, 2026-06. Verfasst von Quang Le Do und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Nutrition, China Medical University, Taichung, Taiwan; Mind-Body Interface Research Center (MBI Lab & Care), China Medical Univ…. Hauptthemen laut MEDLINE: Fatty Acids, Volatile, Biomarkers, Major Depressive Disorder, Gastrointestinal Microbiome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Executive Yuan Republic of China Ministry of Education, Tainan Municipal An-Nan Hospital-China Medical University, Ministry of Education of the People's Republic of China.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND: Major Depressive Disorder (MDD) is increasingly viewed through the lens of the neuroinflammatory hypothesis and gut-brain axis dysfunction. Short-Chain Fatty Acids (SCFAs), the primary metabolites produced by the gut microbiota, are vital signaling molecules that maintain intestinal barrier integrity, modulate peripheral immunity, and influence microglial function. While individual studies suggest altered SCFAs levels in MDD, a definitive, quantitative synthesis establishing a robust biomarker signature is currently lacking. This meta-analysis aimed to precisely characterize the signature of SCFAs (acetic, propionic, butyric, and isobutyric acid) in MDD patients compared to healthy controls. METHODS: We systematically searched major databases across PubMed, Embase, and Web of Science databases for studies quantifying SCFAs levels up to September 15, 2025. Studies examining SCFAs levels in depressed patients and depressive-like murine models, as well as studies investigating SCFAs interventions for depressive-like behavior, were selected for synthesis. Risk of bias was evaluated using the Newcastle-Ottawa Scale. The effect sizes were synthesized using a random-effects model and presented as standardized mean differences. RESULTS: Eight human and 52 murine studies were included in the meta-analyses. Depressed patients showed significantly lower concentrations in blood (plasma and serum) of propionic (SMD = -0.60, p-value = 0.007), butyric (SMD = -0.50, p-value = 0.006), isobutyric (SMD = -0.72, p-value = 0.020), valeric (SMD = -0.43, p-value = 0.040) and isovaleric acids (SMD = -0.75, p-value = 0.002). Secondary analysis of MDD patients confirmed consistent reductions. High heterogeneity was observed. In murine models, SCFAs depletion was frequently observed, while supplementation improved depressive-like behaviors. CONCLUSION: MDD is characterized by a significant, quantifiable deficit in the circulating SCFAs metabolome, which provides strong empirical validation for the gut-brain axis hypothesis in depression. We advocate for the investigation of SCFAs as novel, measurable peripheral biomarkers and targeted therapeutic agents (e.g., butyrate supplementation) for precision nutritional psychiatry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Nutrition, China Medical University, Taichung, Taiwan; Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan.
- Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan.
- Department of Health Care Science, China Medical University, Taichung, Taiwan; Nursing and Medical Technology School, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Viet Nam.
- Department of Preventive Medicine, School of Public Health, Wenzhou Medical University, Zhejiang Province, China.
- Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan; Child Psychiatry Division, Department of Psychi…
- Mind-Body Interface Research Center (MBI Lab & Care), China Medical University Hospital, Taichung, Taiwan; College of Medicine, China Medical University, Taichung, Taiwan; Office of Research and Development, Asia Univer…
Förderung
- Executive Yuan Republic of China Ministry of Education
- Tainan Municipal An-Nan Hospital-China Medical University
- Ministry of Education of the People's Republic of China
- China Medical University Hospital
- China Medical University
- Ministry of Science and Technology, Taiwan
- China Medical University, Taiwan
- National Science and Technology Council
Zitieren
APA
Do, Q. L., Malau, I. A., Nguyen, H. T., Liu, J., Chang, J. P., & Su, K. P. (2026). Circulating Short-Chain Fatty Acid (SCFA) profiles as a biomarker of gut-brain axis dysfunction: A meta-analysis for the SCFA signature in major depression. Biomedical Journal, 49(3), 100968. https://doi.org/10.1016/j.bj.2026.100968
Vancouver
Do QL, Malau IA, Nguyen HT, Liu J, Chang JP, Su KP. Circulating Short-Chain Fatty Acid (SCFA) profiles as a biomarker of gut-brain axis dysfunction: A meta-analysis for the SCFA signature in major depression. Biomedical Journal. 2026;49(3):100968. doi:10.1016/j.bj.2026.100968
BibTeX
@article{Do2026,
author = {Do, Quang Le and Malau, Ikbal Andrian and Nguyen, Hoan Thi and Liu, Jiaming and Chang, Jane Pei-Chen and Su, Kuan-Pin},
title = {Circulating Short-Chain Fatty Acid (SCFA) profiles as a biomarker of gut-brain axis dysfunction: A meta-analysis for the SCFA signature in major depression},
journal = {Biomedical Journal},
year = {2026},
volume = {49},
number = {3},
pages = {100968},
doi = {10.1016/j.bj.2026.100968}
}
EUVIMED